Harness The Real Potential & Power Of AI & New Technologies To Maximise HCP Engagement, Patient Results & Commercial Advancement With

AI-Literate, Customer-Focused & Data-Driven Digital Pharma Marketing Strategies

Grand Ballroom, Grand Connaught Rooms London, 28th January 2026

You will shortly receive an email with a further £20 off, if you don’t receive your discount please email
info@digitalpharmaconference.com

Programme – 28th January 2026

08.15 Registration & Informal Networking

OPENING REMARKS

09.00 GIC Welcome & Morning Co-Chairs’ Opening Remarks

Dr Rene Rust, Head Of Corporate Communications, Almirall

Kishan Rees, Senior Director Video & Digital Content Strategy, Bayer

HIGH-IMPACT DIGITAL STRATEGIES

09.10 Unify & Streamline Your Pharma Digital Strategies To Boost Engagement, Increase Effectiveness & Stand Out From The Competitive Crowd

In an increasingly digital-driven world, are your platforms and processes working at peak efficiency to deliver true value?
There is still a delicate balance to be struck between digital and face-to-face interactions – how can you keep the two working in harmony? What approach provides the greatest benefit to the greatest number of patients?
From 2026 and beyond, scan the digital horizon to assess what is in the pipeline, and its potential impact on the pharma sector
Utilise the most effective metrics to demonstrate your digital success, securing senior buy-in and external engagement

Sara Tea Di Niro, Marketing Specialist, Teva

AI IN ACTION: BUILDING PRACTICAL, TRUSTED & SCALABLE SOLUTIONS IN PHARMA

09.30 Unleashing AI’s Potential Isn’t About Perfection – It’s About Progress. This Session Explores How Organisations Can Apply AI In Real-World Commercial Contexts Through Clear Governance, Cross-Functional Experimentation & A Strong Focus On Trust, Value & Scalability

Establishing the foundations for responsible AI: governance, transparency, and alignment with business goals
Practical examples of AI initiatives that enhance engagement, streamline operations, and unlock insights, while keeping humans in the loop
Navigating ambiguity: how to move from pilot to progress by engaging teams, learning from failure, and scaling what works
Addressing ethical, compliance, and trust considerations to ensure AI supports – not replaces – human judgment and medical responsibility

Antonio Ibarra, Omnichannel Customer & Innovation Lead, Grünenthal Iberia

OPTIMISED HCP ENGAGEMENT

PANEL Q&A

09.50 Capture HCPs’ Valuable Time & Attention By Addressing Fundamental Needs Head-On & Delivering Boosted Engagement Every Time

With an ever-evolving relationship between HCPs and the pharma sector, what is the key to successful HCP engagement in 2026 and beyond?
Assess and compare the merits of different channel strategies to identify the best ways to truly get through to HCPs
Refresh your content and comms to put your company’s best foot forward and drive towards effective patient outcomes
Incorporate data-driven personalisation to create unmissable content that truly speaks to HCPs’ key priorities

Kiren Kaur Dulai, Senior Global Manager Omnichannel Enablement, Mundipharma

Katerina Zampeli, Senior Manager, Business Development & OCE Lead, Novo Nordisk

Becki Morison, EVP, Global Product Strategy & International Operations, LEO Pharma

Konstantin Ivanov, Commercial Excellence & Operations Head (Hungary, Bulgaria, Romania, Greece), Astellas Pharma

Anastasia Roshchina, CEE Marketing Director For Buscopan No-Spa, Opella

Bonus Session; Reserved For Digital Control Room

10.20 Content Warning: Maintaining Online Compliance Post-Veeva – Safeguarding Pharma Content For 2026 & Beyond

Veeva approval and distribution: the end of the compliance journey or merely the start?
With more content in more markets and in more languages, how do you mitigate online content risk?
Harnessing the power of automation to keep pharma’s online content compliant, continually.
Case Study: How a Top 10 Pharma empowers teams with full visibility of actual content online – globally.

Stephen Hickey, CEO, Digital Control Room

Ciaran Duke, Pharmaceutical Business Director, Digital Control Room

10.35 Morning Refreshment Break & Informal Networking

11.05 How To Orchestrate HCP Engagement Across All Your Events (Without Adding Another System Of Record)

The challenge: Teams juggle CRMs, KOL databases, and event platforms – yet can’t answer “which congresses should our CEO attend?” or coordinate meaningful HCP follow-up across engagements.
The HCP 360 strategy: build a unified intelligence layer to create cross-event visibility, institutional memory, and coordinated orchestration – without replacing what you already have.
Real applications: portfolio planning for leadership, cross-TA KOL coordination, streamlined compliance reporting, omnichannel journey orchestration, and ROI measurement across congresses, adboards, and webinars.

Pierre Metrailler, CEO, Onomi

FROM DATA TO ACTION

11.25 Turning Insights Into Stakeholder Engagement That Moves the Market
A practical journey from signals to decisions—aligning the cross functional team around value-driving actions

Start with the business question: translating brand/portfolio priorities into measurable insight needs (growth, access, experience, resource allocation)
Make insights “stakeholder-ready”: tailoring the same evidence to what matters for HCPs, payers, patients—and for internal teams (field, MSL, access, marketing)
Activate across channels: turning insight into next-best-actions, messaging and orchestration that improves engagement—not noise
Prove and measure impact: selecting outcome-based KPIs and building a closed-loop process from engagement → learning → optimisation

Simone Rebora, Global Marketing Director Oncology, Ipsen

11.45 Bonus Session; Reserved For Inizio Evoke

PRACTICAL AI INNOVATIONS: POWERFUL STRATEGIES WITH PROVEN VALUE

PANEL Q&A

12.00 The Future Is Now! Practical Approaches On Applying AI To Enhance Consumer Experience, Reduce Workloads & Drive Business Efficiencies Without Losing The Human Touch

How can pharma continue to move away from theory and put AI into practice? From content creation to patient interaction, what actionable, results-driven approaches can be implemented today?
Debate the ethics of AI and how your results can be validated: assess the limits of how far AI can be utilised while still remaining compliant, safe and trustworthy
With patients able to access ChatGPT and other AI tools for themselves, how can pharma companies safeguard consumers, encourage the use of proper medical channels, and mitigate the potential spread of misinformation?
Crunch the numbers! With huge volumes of available data, and time a precious resource, utilise AI as a tool to filter and find the most relevant data points, mitigating labour-intensive processes and speeding up deliverable results

Richard Jones, Senior Director, Enterprise Architecture Commercial Practice, Pfizer

Ruben Bueno, Customer Engagement & Business Excellence Senior Director, Novo Nordisk

Alan How, Digital Lead Pharma, Bayer

Dimitri Varsamis PhD, Senior Digital Programmes Lead, Central London Community Healthcare NHS Trust

INNOVATIVE DIGITAL TRANSFORMATION

12.30 Foster A Company-Wide Mindset That Embraces Digital Transformation To Drive Real Results, Without Losing Sight Of The Key Fundamentals

Embrace the change! Promote digital literacy and a forward-looking mindset among senior leadership and employees alike
Highlight critical successes to demonstrate a results-first approach and inspire company-wide digital innovation and adoption
Keep practical actionability in mind and ensure that key marketing and comms fundamentals don’t get lost in the transition to digital
Leverage the latest technologies to upscale digital processes while keeping costs and workloads manageable

Frédéric Baffou, Head of Multichannel & Digital Marketing, Neuromodulation, International, Medtronic

12.50 From Knock-Knock To Click-Click: How RepTwins Are Rewriting Pharma Engagement

For decades, pharma engagement started with a knock on the clinic door. Today, that door is often closed—by time constraints, digital overload, and declining access. This session explores how RepTwins—AI-powered digital brand representatives—are shifting pharma engagement from scheduled interruptions to on-demand conversations. Instead of asking for time, RepTwins wait for intent. Instead of repeating messages, they respond to questions. And instead of replacing human reps, they extend their reach—everywhere, all the time. Attendees will discover how this “click-click” era enables smarter engagement inside HCP workflows, creates compliant scientific dialogue at scale, and redefines what meaningful interaction looks like in modern healthcare.

Kamya Elawadhi, Chief Client Officer, Doceree

13.05 Lunch & Informal Networking For Speakers, Delegates & Partners

13.40 Informal Breakout Discussions

A) Employee Engagement

Suzi Archer, People Engagement Director, Norgine

B) How To Make Omnichannel Feel Personal At Scale

How Are You Balancing Automation & Personalisation In Your Omnichannel Strategy?

Antonio Cravino, Customer Engagement Lead, Sanofi

C) AI Governance

David Wilson, Global Digital Transformation & Innovation Director, Kyowa Kirin

D) Geopolitics

E) Medical Devices

F) Cyber Security

OPENING REMARKS

14.10 Afternoon Co-Chairs’ Opening Remarks

Alan How, Digital Lead Pharma, Bayer

David Wilson, Global Digital Transformation & Innovation Director, Kyowa Kirin

14.20 From GenAI To Agentic AI: What Pharma Commercial Leaders Need To Prepare For 2026

Explain the shift from AI enablement and GenAI tools to agentic AI systems that can reason, orchestrate, and act across the pharma commercial ecosystem.
Examine how pharma organizations are progressing from AI enablement to GenAI and now to agentic AI across launch planning, sales execution, marketing activation, and customer engagement.
Highlight how governance models, risk considerations, and success measures differ for agentic AI compared to GenAI solutions.
Describe how consulting approaches are evolving, including agentic assessments that help organizations prioritize use cases, redesign workflows, and build realistic roadmaps to scale agentic AI, with actionable takeaways for organizational readiness.

Jo Ann Saitta, Head of Data & AI, Inizio Ignite

REGULATION, LEGAL & COMPLIANCE: FIRST-HAND, CRITICAL INSIGHTS

PANEL Q&A

14.35 Reinforce Regulatory Understanding & Compliant Mindsets Across Data, AI & More, To Drive Reputational Strength & Well-Earned Trust

With regulations shaping and guiding the evolution of digital pharma, what is next in the pipeline, and what will the immediate future of regulatory compliance look like?
Foster a culture of widespread communication across different countries, sectors and teams to ensure compliance requirements are always being met
Content creation, data privacy, the use of AI – assess the regulatory pitfalls behind modern digital practices and learn how to avoid them
Alter your mindset! Rather than a negative necessity, how can regulation and compliance be better positioned as a positive force to drive trust and patient safety?

Antonios Roussos, Head of E&C Global Excellence & Innovation, Astellas Pharma Inc.

Antoinette Keane, Executive Director, Head of Ethics & Compliance EUR/INT, formerly Jazz Pharmaceuticals

Anastasia Troyan, Senior Director Global Compliance & Ethics, formerly Teva

Corlia Van Der Walt, Director R&D Partnerships & Legal Compliance, AstraZeneca

PATIENT CENTRICITY & ENGAGEMENT

15.05 Keep Up With Changing Patient Behaviours To Engage Directly & Effectively With This Key Demographic & Put Patient Needs At The Heart Of Your Digital Strategies

The tailored method – how can you craft a patient-first approach, and how does speaking to this audience this differ from HCP engagement?
As patients become very more knowledgeable about their options, and with constant access to “Doctor Google”, ensure that your outreach strategies speak to modern-day concerns
Take advantage of tech advances and the power of AI to create relevant and personalised content that lets patients know they are seen and heard
Maintain trust and reputational strength by positioning transparency, ethics and regulatory compliance foremost in your patient-centric mindset

Simeón Baker, Director of External Affairs, Genomics England

15.25 Bonus Session; Reserved For Tech Mahindra

15.40 Afternoon Refreshment Break & Informal Networking

16.15 Bonus Session; Reserved For Resolver

MEASURING & SHOWCASING DIGITAL SUCCESS

16.30 Avoid Valueless Vanity Metrics & Focus On Your Pharma Brand’s Most Pure & Powerful Narrative Through Cutting-Edge Measurements & Metrics

Cut through the noise and get to the heart of the data, to see what is truly working and where the most value is being added
Control the narrative – what does success look like to your organisation? Are your current metrics capitalising on this, and best positioned to showcase what matters most?
How can company-wide data points be brought together to tell a cohesive story, securing engagement and buy-in at all levels?
Contrast different measurement tools and reporting strategies to find out what best broadcasts your message

OMNICHANNEL SUCCESS IN 2026 & BEYOND

PANEL Q&A

16.50 Get To Know Your Audience! Revolutionise Your Omnichannel Strategy By Assessing The Effectiveness Of All Channels & Platforms To Truly Speak To Your Target Consumers

Generate brand loyalty and trust by co-ordinating a coherent, unified omnichannel strategy that delivers at every touchpoint
Incorporate the latest data insights to remove friction and identify weak spots in your customs journeys, as well as adding crucial personalisation to make your content truly memorable
Put the user first! Ensure your omnichannel approach doesn’t just work behind the scenes, but prioritises customer experience
One size doesn’t fit all – tailor your content across all apps and platforms to deliver timely and concise messaging without bombarding your audiences

Pablo Regueras Escudero, Commercial Co-Lead Oncology/Oncohematology Unit Marketing, Astellas Pharma

Özlem Önal Baran, International Brand Lead, IMCO, AbbVie

Enis Otuk, Country Manager – Ireland, Viatris

Josep Noguer, Head of Patient & Customer Experience, Ferrer

MAXIMISING DIGITAL TOUCHPOINTS

17.20 Chart An Effective Roadmap Between Digital Touchpoints To Smooth Out Consumer Journeys & Ensure That Digital Interaction Never Feels Like A Chore

Evaluate the full consumer experience, step by step, to create a smooth and cohesive transition across multiple digital touchpoints
Assess the merits of the latest technologies to enhance your customers’ digital experience without exceeding budgets
Embed personalisation and speed up digital journeys by using customer data in a tailored and effective way
Collaborate across multiple internal teams, channels and processes to join up disparate elements into a coherent and seamless customer experience

17.40 Afternoon Co-Chairs’ Closing Remarks & Close Of Conference

Alan How, Digital Lead Pharma, Bayer

David Wilson, Global Digital Transformation & Innovation Director, Kyowa Kirin